Phase Ib Study of AlpeliSib With PEmbroLizumab in Patients With mEtastatic Breast caNcer or melanomA (SELENA)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University Health Network, Toronto
Alliance for Clinical Trials in Oncology
Wake Forest University Health Sciences
NRG Oncology
Institut Cancerologie de l'Ouest
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Brigham and Women's Hospital
M.D. Anderson Cancer Center
Stanford University
Wake Forest University Health Sciences
Fondazione del Piemonte per l'Oncologia
Mayo Clinic
Dana-Farber Cancer Institute
Kaiser Permanente
Mayo Clinic
Washington University School of Medicine
University of Florida
Memorial Sloan Kettering Cancer Center
Essen Biotech
Essen Biotech
St. Jude Children's Research Hospital
City of Hope Medical Center
University of Nebraska
M.D. Anderson Cancer Center
University of Southern California
The Netherlands Cancer Institute
Ohio State University Comprehensive Cancer Center
Mayo Clinic
The First Affiliated Hospital of Xinxiang Medical College
University Health Network, Toronto
Abramson Cancer Center at Penn Medicine
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
Young Adult Survivors United
Virginia Commonwealth University
Institut Bergonié
Hadassah Medical Organization
Hadassah Medical Organization
Institut Curie
Mayo Clinic
Cancer Research UK
Milton S. Hershey Medical Center
NuCana plc
University of Virginia
University Health Network, Toronto
Duke University
NRG Oncology
UNICANCER